T 0019/90 (Onco-Mouse) of 3.10.1990

European Case Law Identifier:

ECLI:EP:BA:1990:T001990.19901003

Date of decision:

03 October 1990

Case number:

T 0019/90

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

A

Download and more information:

Decision text in EN (PDF, 1Â MB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	OJ \| Published

Title of application:

-

Applicant name:

Harvard

Opponent name:

-

Board:

3.3.02

Headnote:

1. The exception to patentability under Article 53(b) EPC applies to certain categories of animals but not to animals as such.
2. In particular in the case of genetic manipulation of animals involving, as in this case, the insertion of an activated oncogene, there are compelling reasons to consider the provisions of Article 53(a) EPC in relation to the question of patentability.

Relevant legal provisions:

European Patent Convention 1973 Art 53(a)
European Patent Convention 1973 Art 53(b)
European Patent Convention 1973 Art 83

Keywords:

Patentability of animals
Genetic manipulation of animals - morality
Transgenic animals
Sufficient disclosure (yes)

Catchwords:

-

Cited decisions:

-

Citing decisions:

G 0001/98
G 0002/12
G 0002/13
G 0003/19
J 0018/99
T 0435/91
T 0242/92
T 0612/92
T 0694/92
T 0820/92
T 0149/93
T 0356/93
T 0020/94
T 0199/94
T 0383/94
T 0386/94
T 1054/96
T 0354/97
T 0743/97
T 0462/98
T 0728/98
T 1165/98
T 0944/99
T 0036/00
T 0363/00
T 0499/00
T 0505/00
T 0751/00
T 1084/00
T 0008/01
T 0351/01
T 0423/01
T 0579/01
T 0599/01
T 0866/01
T 0378/02
T 0437/02
T 0946/02
T 0315/03
T 0606/03
T 0759/03
T 0843/03
T 0877/03
T 0094/04
T 0275/04
T 0326/04
T 0542/04
T 0562/04
T 0596/04
T 0843/04
T 0907/04
T 1262/04
T 1374/04
T 0021/05
T 0035/05
T 0083/05
T 0297/05
T 0602/05
T 0724/05
T 0905/05
T 1287/05
T 0063/06
T 0309/06
T 0364/06
T 0394/06
T 1074/06
T 1188/06
T 1202/06
T 1384/06
T 0021/07
T 0293/07
T 1158/07
T 1440/07
T 2002/07
T 0176/08
T 0230/08
T 0491/08
T 1069/08
T 1496/08
T 1740/08
T 1904/08
T 2006/08
T 2224/08
T 0018/09
T 0967/09
T 1150/09
T 2101/09
T 0034/10
T 0915/10
T 1152/10
T 1383/10
T 1846/10
T 2329/10
T 2533/10
T 0247/11
T 0348/11
T 2232/11
T 0284/12
T 1224/12
T 1825/12
T 2220/12
T 0305/13
T 1045/13
T 2374/13
T 1111/14
T 1553/15
T 0358/16
T 2607/16
T 0291/17
T 0720/17
T 1153/17
T 0241/18
T 0395/18
T 2131/19

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t900019ex1.html

Date retrieved: 17 May 2021

70 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Offical Journal of the EPO

X OJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)

X OJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)

X OJ EPO 2020, A119 - Opinion of the Enlarged Board of Appeal dated 14 May 2020 - G 3/19

X OJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)

X OJ EPO 2016, A27 - Decision of the Enlarged Board of Appeal dated 25 March 2015 - G 2/12

Case Law Book: I Patentability

X CLR I B 1.2 Basic principles

X CLR I B 2.1.2 Scope of exception under Rule 28(d) EPC

X CLR I B 2.2.2 Assessment of an objection according to Article 53(a) EPC

X CLR I B 2.2.2.A Difference from test under Rule 28(d) EPC

X CLR I B 3.2 Animals and animal varieties

X CLR I B 3.3.1 Essentially biological processes for the production of animals

X CLR I E 2 Reproducibility and sufficiency of disclosure

Case Law Book: II Conditions to be met by an Application

X CLR II C 5.2 Indication of at least 'one way'

X CLR II C 5.4 Invention to be performed over whole range claimed

X CLR II C 6.1 Repeatability

X CLR II C 7.1.4 Broad claims

X CLR II C 9 Evidence

X CLR II D 3.1.6 Enabling disclosure in the priority document

Case Law of the Enlarged Board

X G 0001/98 (Transgenic plant/NOVARTIS II) of 20.12.1999

X G 0002/12 () of 25.3.2015

X G 0002/13 () of 25.3.2015

X G 0003/19 (Pepper (follow-up to ÂTomatoes IIÂ and ÂBroccoli IIÂ)) of 14.5.2020

General Case Law

X J 0018/99 (Representation under Article 134(7) EPC) of 1.10.2002

X T 0435/91 (Detergents) of 9.3.1994

X T 0242/92 (Invasive microorganisms/LELAND STANFORD JUNIOR UNIVERSITY) of 26.5.1993

X T 0612/92 (Monocotyledonous plants/Rijksuniversiteit Leiden) of 28.2.1996

X T 0694/92 (Modifying plant cells) of 8.5.1996

X T 0820/92 (Contraceptive method) of 11.1.1994

X T 0149/93 (RETINOIDS/Kligman II) of 23.3.1995

X T 0356/93 (Plant cells) of 21.2.1995

X T 0020/94 (Amorphous TPM/ENICHEM) of 4.11.1998

X T 0386/94 (Chymosin) of 11.1.1996

X T 0743/97 (Thrombolytic proteins/GENETICS INSTITUTE) of 26.7.2000

X T 0728/98 (Pure terfenadine/ALBANY) of 12.5.2000

X T 0036/00 (Proteinase deficient fungi/GENENCOR) of 2.10.2003

X T 0499/00 (Papier pour plaques de plÃ¢tre/LAFARGE PLATRES) of 28.1.2003

X T 0751/00 (Polyol fatty acid esters/PROCTER & GAMBLE) of 21.5.2003

X T 1084/00 (HIV-3 variants/INNOGENETICS) of 11.4.2003

X T 0351/01 (Tissue Factor Protein/GENENTECH) of 2.7.2003

X T 0423/01 (LÃ¤ngenpolymorphismen/MAX-PLANCK-GESELLSCHAFT) of 25.3.2004

X T 0579/01 (Cytoplasmic male sterile plants/ENZA ZADEN) of 30.6.2004

X T 0866/01 (Euthanasia Compositions/MICHIGAN STATE UNIV.) of 11.5.2005

X T 0378/02 (Analysis of polynucleotide sequences/OXFORD GENE TECHNOLOGY) of 12.10.2005

X T 0315/03 (Transgenic animals/HARVARD) of 6.7.2004

X T 0759/03 (FIV/ST. VINCENT'S INSTITUTE, et al) of 17.8.2006

X T 0843/03 (Human papillomavirus/THE UNIVERSITY OF ROCHESTER) of 25.10.2004

X T 0326/04 (Granular composition/PROCTER) of 12.12.2006

X T 0562/04 (Factor VIII/von Willebrand factor complex/OCTAPHARMA) of 14.2.2006

X T 1262/04 (Light detection in mammals/LELAND STANFORD) of 7.3.2007

X T 1374/04 (Stem cells/WARF) of 7.4.2006

X T 0021/05 (CTL responses to HCV/SCRIPPS) of 13.7.2006

X T 0083/05 (Broccoli/PLANT BIOSCIENCE) of 22.5.2007

X T 0297/05 (Electrochemiluminescence/BIOVERIS) of 2.2.2006

X T 0063/06 () of 24.6.2008

X T 0309/06 (Phospholipase A1/SANKYO) of 25.10.2007

X T 0364/06 (Multiplex DNA amplification/BAYLOR) of 22.3.2007

X T 1074/06 (Infertility/ARS) of 9.8.2007

X T 1188/06 (Molecular evolution/BIOINVENT) of 18.10.2007

X T 0293/07 (Cerebrale IschÃ¤mien/EHRENREICH et al.) of 24.7.2008

X T 1440/07 (Gene expression/SERONO) of 23.9.2009

X T 0491/08 (Improved immunogenicity/GOVERNMENT USA) of 21.10.2010

X T 1069/08 (Desaturase/CALGENE) of 8.9.2011

X T 2006/08 (Conjugated factor IX/BIOVITRUM) of 18.10.2011

X T 0018/09 (Neutrokine/HUMAN GENOME SCIENCES) of 21.10.2009

X T 0967/09 (Influenza vaccines/ABBOTT BIOLOGICALS) of 4.11.2014

X T 0915/10 (Soybean event/MONSANTO) of 11.6.2015

X T 1383/10 (Mutants PB92, S309 serine proteases; low temperature detergent/ … of 24.6.2014

X T 1846/10 (Attenuated Lawsonia/BOEHRINGER) of 12.3.2015

X T 2232/11 () of 20.1.2017

X T 1045/13 (Nerve growth factor/Milkhaus) of 23.10.2017